Skip to main content

Table 2 Clinical and demographic characteristics of patients with HCV

From: Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement

Variable

HCV without articular involvement (n = 31)

HCV with articular involvement (n = 8)

Age (years), mean (range)

58 (35–75)

67 (50–79)

Polyarthritis, no. (%)

0 (0)

3 (37.5)

Polyarthralgias, no. (%)

0 (0)

5 (62.5)

Cryoglobulinemia, no. (%)

5 (16)

2 (25)

Transaminase U/L, mean ± SD

  

   ALT

74 ± 41

72 ± 29

   AST

119 ± 79

102 ± 47

Liver biopsy*

  

   Slight activity hepatitis

12

3

   Minimum activity hepatitis

4

0

   Moderate activity hepatitis

8

1

   Severe activity hepatitis

5

2

HCV genotype

  

   1a

2

0

   2a

2

2

   3a

2

0

   2a/2c

4

0

   1b

17

4

   4c/4d

2

0

  1. *Four biopsies lacking. Four genotypes lacking. ALT, alanine aminotransferase; AST, aspartate aminotransferase; HCV, hepatitis C virus; U/L, unit/liter.